Long term systemic corticosteroid therapy-associated measures. Description of French general practitioners'practices regarding;Mesures adjuvantes à une corticothérapie systémique prolongée. Pratiques des médecins généralistes Français

Revue du Praticien

Volumn 59, Issue 8 SUPPL, 2009, Pages 19-24

  Perdoncini Roux, Aurélie ^a   Blanchon, Thierry ^b,c   Hanslik, Thomas ^b,c,d   Lasserre, Andrea ^b,c   Turbelin, Clément ^b,c   Dorleans, Yves ^b,c   Cabane, Jean ^a   Fardet, Laurence ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLUENZA VACCINE;

ADULT; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHYSIOTHERAPY; PRESCRIPTION; QUESTIONNAIRE; SODIUM RESTRICTION;

ADRENAL CORTEX HORMONES; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TIME FACTORS;

EID: 72249120655     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondaryosteoporosis: a cross sectional study. BMJ 1996;313:344-346. (Pubitemid 26334822)
2. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of cortcosteroidtherapy? J Clin Pharm Ther 2000;25:227-234.
3. AFSSAPS. Traitement médicamenteux de l'ostéoporose cortisonique. Recommandation de bonne pratique, février 2003.
4. Fardet L, Cabane J, Lebbé C, Morel P, Flahault A. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. J Am Acad Dermatol 2007;57:604-609. (Pubitemid 47384921)
5. + retention in man is not mediated by the mineralocorticoid receptor. J Clin Endocrinol Metab 1991;72:1060-1066. (Pubitemid 21921807)
6. el-Shaboury AH, Hayes TM. Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy. Br Med J 1973;2:85-86.
7. Falduto MT, Czerwinski SM, Hickson RC. Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers. J Appl Physiol 1990;69:1058-1062.
8. Liddle GW. Effects of anti-inflammatory steroids on electrolyte metabolism. Ann N Y Acad Sci 1959;82:854-867.
9. Gennari FJ. Hypokalemia. N Engl J Med 1998;339:451-458.
10. Chalmers A, Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994;21:1203-1206. (Pubitemid 24234652)
11. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994;236:619-632.
12. Fardet L, Hanslik T, Blanchon T, et al. Long-term systemic corticosteroid-therapy associated measures: description of the French internal medicine physicians'practices. Rev Med Interne. 2008;29:975-980.